<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We compared the effects of modified progressive thermal preconditioning (<z:chebi fb="0" ids="52242">PTP</z:chebi>) and whole-body thermal preconditioning (TP) on stress responses, <z:mp ids='MP_0003674'>oxidative stress</z:mp> biomarkers, and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> formation, and explored their possible actions through phosphatidylinositol 3-kinase (PI3K)/Akt-dependent heat-shock protein (Hsp)/endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (eNOS) pathways </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We divided four groups of 249 male Wistar rats into nonimmersed controls, TP, and one (1-<z:chebi fb="0" ids="52242">PTP</z:chebi>) and three consecutive cycles (3-<z:chebi fb="0" ids="52242">PTP</z:chebi>) of <z:chebi fb="0" ids="52242">PTP</z:chebi> in a 42Â°C water bath </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated the stress responses, including hemodynamics, total energy transfer, endoplasmic reticulum (ER) stress marker <z:chebi fb="105" ids="17234">glucose</z:chebi>-regulated protein (GRP78), and blood reactive oxygen species level during TP or <z:chebi fb="0" ids="52242">PTP</z:chebi> treatment </plain></SENT>
<SENT sid="3" pm="."><plain>We compared 1-<z:chebi fb="0" ids="52242">PTP</z:chebi>, 3-<z:chebi fb="0" ids="52242">PTP</z:chebi>, or TP effects on <z:mp ids='MP_0003674'>oxidative stress</z:mp>, intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule 1 (ICAM-1), Hsp70, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) activity, and vascular phosphorylated Akt (p-Akt) and eNOS (p-eNOS) expressions in a model of topical <z:chebi fb="2" ids="30808">ferric chloride</z:chebi> (FeCl(3))-induced carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:chebi fb="0" ids="52242">PTP</z:chebi> significantly (P &lt; .05) induced less hemodynamic fluctuations, total energy transfer, ER, and <z:mp ids='MP_0003674'>oxidative stress</z:mp> than TP did </plain></SENT>
<SENT sid="5" pm="."><plain>After 24 or 72 hours of treatment, 1-<z:chebi fb="0" ids="52242">PTP</z:chebi>, 3-<z:chebi fb="0" ids="52242">PTP</z:chebi>, and TP significantly (P &lt; .05) elevated carotid arterial Hsp70, p-Akt, and p-eNOS expression, significantly (P &lt; .05) depressed FeCl(3)-enhanced vascular 2',7'-dichlorodihydrofluorescein diacetate, chemokine (C-X3-C motif) ligand 1 (CX3CL1), 3-nitrotyrosine, <z:chebi fb="0" ids="32585">4-hydroxynonenal</z:chebi>, and ICAM-1 stain, PAI-1, and t-PA activity, <z:mp ids='MP_0002498'>leukocyte infiltration</z:mp> and <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> size, and significantly (P &lt; .05) delayed <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation compared with controls </plain></SENT>
<SENT sid="6" pm="."><plain>3-<z:chebi fb="0" ids="52242">PTP</z:chebi> and TP had a higher (P &lt; .05) protection than 1-<z:chebi fb="0" ids="52242">PTP</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>PI3K/Akt, Hsp70, or N(G)-<z:chebi fb="13" ids="29785">nitro</z:chebi>-l-arginine <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> <z:chebi fb="16" ids="36807">hydrochloride</z:chebi> (L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e>) inhibitors significantly (P &lt; .05) depressed 3-<z:chebi fb="0" ids="52242">PTP</z:chebi> and TP-induced vascular protection </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Repetitive <z:chebi fb="0" ids="52242">PTP</z:chebi> is better than single <z:chebi fb="0" ids="52242">PTP</z:chebi> to hinder <z:mp ids='MP_0005048'>thrombosis</z:mp> formation via reinforcing PI3K/Akt-dependent Hsp70/eNOS signaling </plain></SENT>
</text></document>